1. Paules C, Subbarao K. Influenza. Lancet (London, England). 2017;390(10095):697-708.
2. World Health Organization. Influenza (Seasonal) 2018. Available from: https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal) Accessed November 10, 2021
3. Mertz D, Kim TH, Johnstone J, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ (Clinical research ed). 2013;347:f5061.
4. Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiology and molecular biology reviews : MMBR. 2012;76(1):16-32.
5. Guo XJ, Thomas PG. New fronts emerge in the influenza cytokine storm. Seminars in immunopathology. 2017;39(5):541-550.
6. Paats MS, Bergen IM, Hanselaar WE, et al. Local and systemic cytokine profiles in nonsevere and severe community-acquired pneumonia. The European respiratory journal. 2013;41(6):1378-1385.
7. Brown PM, Schneeberger DL, Piedimonte G. Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity. Paediatric respiratory reviews. 2015;16(4):232-240.
8. Bian JR, Nie W, Zang YS, Fang Z, Xiu QY, Xu XX. Clinical aspects and cytokine response in adults with seasonal influenza infection. International journal of clinical and experimental medicine. 2014;7(12):5593-5602.
9. Teijaro JR. Cytokine storms in infectious diseases. Seminars in immunopathology. 2017;39(5):501-503.
10. Wong SS, Oshansky CM, Guo XJ, et al. Severe Influenza Is Characterized by Prolonged Immune Activation: Results From the SHIVERS Cohort Study. The Journal of infectious diseases. 2018;217(2):245-256.
11. Oldstone MB, Rosen H. Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule. Current topics in microbiology and immunology. 2014;378:129-147.
12. Ryabkova VA, Churilov LP, Shoenfeld Y. Influenza infection, SARS, MERS and COVID-19: Cytokine storm - The common denominator and the lessons to be learned. Clinical immunology (Orlando, Fla). 2021;223:108652.
13. Oliveira EC, Marik PE, Colice G. Influenza pneumonia: a descriptive study. Chest. 2001;119(6):1717-1723.
14. Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F. Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy. Infection and drug resistance. 2020;13:2485-2493.
15. Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harbor perspectives in biology. 2014;6(10):a016295.
16. Blanton L, Mustaquim D, Alabi N, et al. Update: Influenza Activity - United States, October 2, 2016-February 4, 2017. MMWR Morbidity and mortality weekly report. 2017;66(6):159-166.
17. Del Giudice M, Gangestad SW. Rethinking IL-6 and CRP: Why they are more than inflammatory biomarkers, and why it matters. Brain, behavior, and immunity. 2018;70:61-75.
18. Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nature immunology. 2015;16(5):448-457.
19. Herold S, Becker C, Ridge KM, Budinger GR. Influenza virus-induced lung injury: pathogenesis and implications for treatment. The European respiratory journal. 2015;45(5):1463-1478.
20. Deshmane SL, Kremlev S, Amini S, Sawaya BE. Monocyte chemoattractant protein-1 (MCP-1): an overview. Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research. 2009;29(6):313-326.
21. Wang J, Nikrad MP, Travanty EA, et al. Innate immune response of human alveolar macrophages during influenza A infection. PloS one. 2012;7(3):e29879.
22. Liu Y, Chen H, Sun Y, Chen F. Antiviral role of Toll-like receptors and cytokines against the new 2009 H1N1 virus infection. Molecular biology reports. 2012;39(2):1163-1172.
23. Shen Z, Chen Z, Li X, et al. Host immunological response and factors associated with clinical outcome in patients with the novel influenza A H7N9 infection. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014;20(8):O493-500.
24. Narasaraju T, Yang E, Samy RP, et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. The American journal of pathology. 2011;179(1):199-210.
25. Ashar HK, Mueller NC, Rudd JM, et al. The Role of Extracellular Histones in Influenza Virus Pathogenesis. The American journal of pathology. 2018;188(1):135-148.
26. Block H, Zarbock A. A Fragile Balance: Does Neutrophil Extracellular Trap Formation Drive Pulmonary Disease Progression? Cells. 2021;10(8).
27. Lazzaretto B, Fadeel B. Intra- and Extracellular Degradation of Neutrophil Extracellular Traps by Macrophages and Dendritic Cells. Journal of immunology (Baltimore, Md : 1950). 2019;203(8):2276-2290.
28. Mehta HM, Malandra M, Corey SJ. G-CSF and GM-CSF in Neutropenia. Journal of immunology (Baltimore, Md : 1950). 2015;195(4):1341-1349.
29. Garbers C, Heink S, Korn T, Rose-John S. Interleukin-6: designing specific therapeutics for a complex cytokine. Nature reviews Drug discovery. 2018;17(6):395-412.
30. Sheppard M, Laskou F, Stapleton PP, Hadavi S, Dasgupta B. Tocilizumab (Actemra). Human vaccines & immunotherapeutics. 2017;13(9):1972-1988.
31. Mihara M, Hashizume M, Yoshida H, Suzuki M, Shiina M. IL-6/IL-6 receptor system and its role in physiological and pathological conditions. Clinical science (London, England : 1979). 2012;122(4):143-159.
32. Zongfei J, Rongyi C, Xiaomeng C, et al. In vitro IL-6/IL-6R Trans-Signaling in Fibroblasts Releases Cytokines That May Be Linked to the Pathogenesis of IgG4-Related Disease. Frontiers in immunology. 2020;11:1272.
33. Rello J, Waterer GW, Bourdiol A, Roquilly A. COVID-19, steroids and other immunomodulators: The jigsaw is not complete. Anaesthesia, critical care & pain medicine. 2020;39(6):699-701.
34. Wang H, Aloe C, Wilson N, Bozinovski S. G-CSFR antagonism reduces neutrophilic inflammation during pneumococcal and influenza respiratory infections without compromising clearance. Sci Rep. 2019;9(1):17732.
35. Scalzo-Inguanti K, Monaghan K, Edwards K, et al. A neutralizing anti-G-CSFR antibody blocks G-CSF-induced neutrophilia without inducing neutropenia in nonhuman primates. Journal of leukocyte biology. 2017;102(2):537-549.